RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hassan Ashktorab to Benzimidazoles

Back to Details
This is a "connection" page, showing publications Hassan Ashktorab has written about Benzimidazoles.
Hassan Ashktorab
Connection Strength
0.198
Benzimidazoles
  1. Najar MA, Aravind A, Dagamajalu S, Sidransky D, Ashktorab H, Smoot DT, Gowda H, Prasad TSK, Modi PK, Chatterjee A. Hyperactivation of MEK/ERK pathway by Ca2+ /calmodulin-dependent protein kinase kinase 2?promotes cellular proliferation by activating cyclin-dependent kinases?and minichromosome maintenance protein?in gastric cancer cells. Mol Carcinog. 2021 11; 60(11):769-783.
    View in: PubMed
    Score: 0.198
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support